IBDEI084 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3663,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3663,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,3663,1,5,0)
 ;;=5^Hepatitis C Acute
 ;;^UTILITY(U,$J,358.3,3663,2)
 ;;=^266632
 ;;^UTILITY(U,$J,358.3,3664,0)
 ;;=070.54^^33^282^25
 ;;^UTILITY(U,$J,358.3,3664,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3664,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,3664,1,5,0)
 ;;=5^Hepatitis C, Chronic
 ;;^UTILITY(U,$J,358.3,3664,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,3665,0)
 ;;=571.41^^33^282^26
 ;;^UTILITY(U,$J,358.3,3665,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3665,1,4,0)
 ;;=4^571.41
 ;;^UTILITY(U,$J,358.3,3665,1,5,0)
 ;;=5^Hepatitis, Chronic Persist
 ;;^UTILITY(U,$J,358.3,3665,2)
 ;;=^259093
 ;;^UTILITY(U,$J,358.3,3666,0)
 ;;=571.1^^33^282^27
 ;;^UTILITY(U,$J,358.3,3666,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3666,1,4,0)
 ;;=4^571.1
 ;;^UTILITY(U,$J,358.3,3666,1,5,0)
 ;;=5^Hepatitis, ETOH acute
 ;;^UTILITY(U,$J,358.3,3666,2)
 ;;=^2597
 ;;^UTILITY(U,$J,358.3,3667,0)
 ;;=070.59^^33^282^28
 ;;^UTILITY(U,$J,358.3,3667,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3667,1,4,0)
 ;;=4^070.59
 ;;^UTILITY(U,$J,358.3,3667,1,5,0)
 ;;=5^Hepatitis, Other Viral
 ;;^UTILITY(U,$J,358.3,3667,2)
 ;;=Hepatitis, Other Viral^266631
 ;;^UTILITY(U,$J,358.3,3668,0)
 ;;=V08.^^33^282^19
 ;;^UTILITY(U,$J,358.3,3668,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3668,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,3668,1,5,0)
 ;;=5^HIV + Status (Asymptomatic)
 ;;^UTILITY(U,$J,358.3,3668,2)
 ;;=HIV + Status (Asymptomatic)^303392
 ;;^UTILITY(U,$J,358.3,3669,0)
 ;;=042.^^33^282^20
 ;;^UTILITY(U,$J,358.3,3669,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3669,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,3669,1,5,0)
 ;;=5^HIV Disease (symptomatic)
 ;;^UTILITY(U,$J,358.3,3669,2)
 ;;=HIV Disease (symptomatic)^266500
 ;;^UTILITY(U,$J,358.3,3670,0)
 ;;=780.60^^33^282^16
 ;;^UTILITY(U,$J,358.3,3670,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3670,1,4,0)
 ;;=4^780.60
 ;;^UTILITY(U,$J,358.3,3670,1,5,0)
 ;;=5^Fever
 ;;^UTILITY(U,$J,358.3,3670,2)
 ;;=^336764
 ;;^UTILITY(U,$J,358.3,3671,0)
 ;;=795.51^^33^282^50
 ;;^UTILITY(U,$J,358.3,3671,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3671,1,4,0)
 ;;=4^795.51
 ;;^UTILITY(U,$J,358.3,3671,1,5,0)
 ;;=5^Pos PPD w/o Active TB
 ;;^UTILITY(U,$J,358.3,3671,2)
 ;;=^340572
 ;;^UTILITY(U,$J,358.3,3672,0)
 ;;=466.19^^33^282^1
 ;;^UTILITY(U,$J,358.3,3672,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3672,1,4,0)
 ;;=4^466.19
 ;;^UTILITY(U,$J,358.3,3672,1,5,0)
 ;;=5^ACUTE BRONCHIOLITIS
 ;;^UTILITY(U,$J,358.3,3672,2)
 ;;=^304310
 ;;^UTILITY(U,$J,358.3,3673,0)
 ;;=466.0^^33^282^2
 ;;^UTILITY(U,$J,358.3,3673,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3673,1,4,0)
 ;;=4^466.0
 ;;^UTILITY(U,$J,358.3,3673,1,5,0)
 ;;=5^ACUTE BRONCHITIS
 ;;^UTILITY(U,$J,358.3,3673,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,3674,0)
 ;;=518.6^^33^282^4
 ;;^UTILITY(U,$J,358.3,3674,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3674,1,4,0)
 ;;=4^518.6
 ;;^UTILITY(U,$J,358.3,3674,1,5,0)
 ;;=5^ALLERG BRONCHOPUL ASPERGILLOSI
 ;;^UTILITY(U,$J,358.3,3674,2)
 ;;=^10945
 ;;^UTILITY(U,$J,358.3,3675,0)
 ;;=031.0^^33^282^5
 ;;^UTILITY(U,$J,358.3,3675,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3675,1,4,0)
 ;;=4^031.0
 ;;^UTILITY(U,$J,358.3,3675,1,5,0)
 ;;=5^ATYPICAL MYCOBACTERIA
 ;;^UTILITY(U,$J,358.3,3675,2)
 ;;=^101018
 ;;^UTILITY(U,$J,358.3,3676,0)
 ;;=486.^^33^282^6
 ;;^UTILITY(U,$J,358.3,3676,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3676,1,4,0)
 ;;=4^486.
 ;;^UTILITY(U,$J,358.3,3676,1,5,0)
 ;;=5^ATYPICAL PNEUMONIA
 ;;^UTILITY(U,$J,358.3,3676,2)
 ;;=^95632
